Clinical Trial Update: Respiratory Muscle Strength and Aerobic Capacity in Scleroderma

View source ↗

Summary

A Firat University-sponsored clinical trial evaluating respiratory muscle strength and aerobic capacity in patients with systemic sclerosis (scleroderma), curre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Sclerosis

Snippet

Sponsor: Firat University | Conditions: Scleroderma | Status: RECRUITING